You are currently visiting in a browser which is not supported. This may reduce the functionality of the website. For the best experience, please upgrade your browser, or switch to a supported browser. For a list of supported browsers visit:

Trends Spotlight: Three Areas of Focus to Reduce CLABSIs

Medline sits down with Association for Vascular Access leadership about how industry can improve patient safety through standardized practices

Northfield, Ill., Oct. 11, 2017 – The number of central line-associated blood stream infections has decreased because of increased infection prevention efforts in the last five to ten years, a drop of 58 percent according to the CDC. However, hospitals are still seeing numbers that are too high and it’s still one of the most expensive hospital-acquired infections. The Joint Commission estimates 250,000 CLABSIs occur each year.

Ramzy Nasrallah, CEO of the Association for Vascular Access (AVA), says the industry is improving how it listens and takes action on patient feedback. Medline recently sat down with him at the AVA Annual Scientific Meeting in Phoenix to learn more about top trends the organization recognizes will help reduce readmissions and lower infection rates, as it relates to peripheral IV use in hospitals.


Data that shows peripheral IVs were often overlooked as the source of complication and infection. Hospitals are recognizing where the problems exist, compared to 10 years ago where there was still some ambiguity. AVA promotes evidence-based clinical practice, and with its “Save That Line” campaign, which helps to educate clinicians about the most up-to-date care techniques as well and simple, basic practices to improve compliance printed on items like pocket cards.


For AVA, lack of education for line access and maintenance continues to be an area of concern. In a recent study, significant deficiency in knowledge or misinformation related to the use of CHG/alcohol in newborn babies and central line-associated blood stream infections was discovered. Once an education program was completed, there was a greater understanding from the clinicians in the study.


More than 300 million peripheral IV catheters are sold each year with more than 60 percent of hospitalized patients needing an IV catheter during their stay. With clinicians working with the insertion and maintenance for a tremendous amount of lines, AVA has found common mistakes include the premature removal of the line, clinicians not using ultrasound guidance or the improper insertion. Through certification and standardization, hospitals can enhance patient outcomes by eliminating gaps in their practices.

Interview opportunities to discuss industry trends are available with Ramzy Nasrallah, CEO of the Association for Vascular Access, and Barb Connell, vice president of medical affairs, Medline. Connell can share insights into Medline’s collaboration with clinicians to create and develop new solutions that will eliminate variance for vascular access.

To learn more about AVA’s Annual Scientific Meeting and the association’s goals for vascular access and its impact on the patient experience, check out

Read more about expanding clinician thinking around peripherally inserted catheters and blood stream infections at

Visit AVA’s course catalog here. To learn more about Medline University’s continuing education that includes peripheral IV therapy and best practices for nurses click here.

About Medline

Medline is a global manufacturer and distributor serving the healthcare industry with medical supplies and clinical solutions that help customers achieve both clinical and financial success. Headquartered in Northfield, Ill., the company offers 350,000+ medical devices and support services through more than 1,400 direct sales representatives who are dedicated points of contact for customers across the continuum of care. For more information on Medline, go to or to connect with Medline on its social media channels.

About AVA

The Association for Vascular Access (AVA) is an organization of healthcare professionals founded in 1985 to support and promote the specialty of vascular access. AVA’s mission is three-fold: Protect the Patient, Educate the Clinician, Save the Line. AVA represents and advances the vascular access specialty and community, and defines standards of vascular access through an evidence-based approach to enhance healthcare and patient outcomes. Today, its multidisciplinary membership advances research, provides professional and public education to shape practice and enhance patient outcomes, and partners with the device manufacturing community to bring about evidence-based innovations in vascular access. Learn more at

2018-06-05T15:25:06+00:00 Newsroom|